U-Ploid Announces Breakthrough Technology to Overcome Age-Related Infertility

"Our team is developing technology that directly targets the root cause of age-related female infertility," said Dr Chloe Charalambous, Co-founder & COO of U-Ploid Biotechnologies. "By improving the health of older eggs, we have the opportunity to help millions of people in their fertility journey." "Our team is developing technology that directly targets the root cause of age-related female infertility," said DrChloe Charalambous, Co-founder & COO of U-Ploid Biotechnologies. "By...
Comunicato Precedente

next
Comunicato Successivo

next
OXFORD, England, (informazione.it - comunicati stampa - salute e benessere)

"Our team is developing technology that directly targets the root cause of age-related female infertility," said Dr Chloe Charalambous, Co-founder & COO of U-Ploid Biotechnologies. "By improving the health of older eggs, we have the opportunity to help millions of people in their fertility journey."

There is a growing need to radically improve IVF as more people choose to start families later in life. Egg cell quality is a key factor in fertility outcomes for would-be parents. U-Ploid's proprietary technology repairs decades of damage accumulated by eggs, a novel approach that aims to improve the viability of older eggs within an IVF cycle.

"We are thrilled to introduce U-Ploid's breakthrough technology, a significant step forward in addressing the global challenge of age-related infertility," said Dr Jordan Abdi, Co-founder & CEO. "By improving egg quality, we aim to dramatically increase the propensity for successful pregnancies through IVF."

U-Ploid is dedicated to collaborating with leading fertility clinics to bring this transformative technology to patients. The company is preparing clinical studies to validate the efficacy and safety of its platform and is committed to obtaining regulatory approvals for widespread adoption.

About U-Ploid Biotechnologies

U-Ploid is a biotechnology company developing next-generation fertility therapeutics to address the global challenge of age-related infertility. Co-founded by Jordan Abdi, Chloe Charalambous, and Alexandre Webster, U-Ploid is pioneering innovative solutions to improve IVF outcomes and expand the window of reproductive opportunity. The company's technology is designed to increase the quality of older eggs, restoring their potential to support healthy pregnancies. U-Ploid is committed to improving access to fertility care and envisions a future where anyone who wants to start a family, can.

Media Contact:[email protected] 

Cision View original content:https://www.prnewswire.co.uk/news-releases/u-ploid-announces-breakthrough-technology-to-overcome-age-related-infertility-302241485.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Slide ShowSlide Show
Non disponibili